Participation in a high-profile conference like Barclays' can enhance Alvotech's visibility among investors and industry peers. The fireside chat and one-on-one meetings provide a platform to showcase their biosimilar medicines, potentially leading to increased investor interest and a positive short-term impact on the stock price.